Bausch + Lomb Corp
F:S2L
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bausch + Lomb Corp
F:S2L
|
CA |
|
Imperial Brands PLC
F:ITBA
|
UK |
|
M
|
Moderna Inc
SWB:0QF
|
US |
|
Agree Realty Corp
F:AGL
|
US |
|
C
|
China Petroleum & Chemical Corp
XHAM:CHU
|
CN |
|
C
|
Cardinal Health Inc
DUS:CLH
|
US |
|
Red Violet Inc
NASDAQ:RDVT
|
US |
|
BOK Financial Corp
F:BJR
|
US |
|
Canadian Imperial Bank of Commerce
TSX:CM
|
CA |
|
C
|
Cass Information Systems Inc
F:CC3
|
US |
|
Anglo American Platinum Ltd
OTC:ANGPY
|
ZA |
|
M
|
Moderna Inc
F:0QF
|
US |
|
C
|
Cardinal Health Inc
XMUN:CLH
|
US |
|
Caixabank SA
F:48CA
|
ES |
|
BioNTech SE
NASDAQ:BNTX
|
DE |
|
H
|
Henry Schein Inc
XHAM:HS2
|
US |
|
N
|
Nikon Corp
DUS:NKN
|
JP |
|
A
|
Abbott Laboratories
F:ABL
|
US |
|
H
|
Helmerich and Payne Inc
XBER:HPC
|
US |
|
Cambricon Technologies Corp Ltd
SSE:688256
|
CN |
|
M
|
MGIC Investment Corp
XMUN:MGC
|
US |
|
V
|
Varonis Systems Inc
F:VS2
|
US |
|
I
|
Isetan Mitsukoshi Holdings Ltd
DUS:4HP
|
JP |
Wall St Price Targets
S2L Price Targets Summary
Bausch + Lomb Corp
According to Wall Street analysts, the average 1-year price target for S2L is 16.12 EUR with a low forecast of 13.77 EUR and a high forecast of 20.58 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is S2L's stock price target?
Price Target
16.12
EUR
According to Wall Street analysts, the average 1-year price target for S2L is 16.12 EUR with a low forecast of 13.77 EUR and a high forecast of 20.58 EUR.
What is the Revenue forecast for Bausch + Lomb Corp?
Projected CAGR
6%
Over the last 6 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 6%.
What is the Gross Profit forecast for Bausch + Lomb Corp?
Projected CAGR
7%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 8 years is 7%.
What is the Operating Income forecast for Bausch + Lomb Corp?
Projected CAGR
76%
Over the last 6 years, the compound annual growth rate for Operating Income has been -13%. The projected CAGR for the next 3 years is 76%.
